Patents - Global Data - Dimensions
Application
Anti-tissue factor antibody-drug conjugate and its use in the treatment of cancer
Applicants
- Genmab (Denmark)
[NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present invention relates to, for example, colon cancer, non-small cell lung cancer, pancreatic cancer, head and neck cancer, bladder cancer, endometrial cancer, by administering an antibody-drug conjugate that binds to tissue factor (TF). Provided are methods and compositions for treating cancers such as esophageal cancer and prostate cancer. The present invention is also used in TF for use in the treatment of cancers (eg, colon cancer, non-small cell lung cancer, pancreatic cancer, head and neck cancer, bladder cancer, endometrial cancer, esophageal cancer, and prostate cancer). Provided are manufactured articles and compositions comprising said antibody-drug conjugate to which it binds.
Patent Family Records (14)
Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer - Patents.com
Genmab (Denmark), Genmab AS アビドイエ オイウェイル オー．, アビドイエ オイウェイル オー．, サテン デイビッド, (...more)
2024, JP-7471227-B2
Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
Genmab (Denmark), Genmab AS アビドイエ オイウェイル オー．, アビドイエ オイウェイル オー．, サテン デイビッド, (...more)
2024, JP-2024045219-A
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
Genmab (Denmark), Genmab AS RANGWALA RESHMA ABDULLA, BREIJ ESTHER CORNELIA WILHELMINA, SATIJN DAVID, (...more)
2021, US-20210030888-A1
Anti-tissue factor antibody-drug conjugate and its use in the treatment of cancer
Genmab (Denmark), Genmab AS アビドイエ オイウェイル オー．, アビドイエ オイウェイル オー．, サテン デイビッド, (...more)
2021, JP-2021515017-A
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
Genmab (Denmark), Genmab AS BREIJ ESTHER, SATIJN DAVID, VERPLOEGEN SANDRA, (...more)
2021, EP-3762032-A4
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
Genmab (Denmark), Genmab AS BREIJ ESTHER, SATIJN DAVID, VERPLOEGEN SANDRA, (...more)
2021, EP-3762032-A1
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
GENMAB AS, Genmab (Denmark) BREIJ ESTHER, SATIJN DAVID, RANGWALA RESHMA ABDULLA, (...more)
2020, SG-11202007865V-A
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER.
GENMAB AS, Genmab (Denmark) VERPLOEGEN SANDRA, SATIJN DAVID, BREIJ ESTHER, (...more)
2020, MX-2020008613-A
Anti-tissue factor antibody-drug conjugates and their use in cancer treatment
GENMAB A, Genmab (Denmark) RANGWALA RESHMA ABDULLA, BREIJ ESTHER, SATIJN DAVID, (...more)
2020, KR-20200130356-A
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
GENMAB AS, Genmab (Denmark)
2020, IL-276768-A
METHOD FOR TREATING CANCER IN A SUBJECT, CASE, USE OF AN ANTIBODY-PHARMACEUTICAL CONJUGATE THAT LINKS TO THE TISSUE FACTOR, AND, ANTIBODY-PHARMACEUTICAL CONJUGATE.
GENMAB AS, Genmab (Denmark) ANDREAS LINGNAU, DAVID SATIJN, ESTHER BREIJ, (...more)
2020, BR-112020018092-A2
Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
Genmab (Denmark), Genmab AS BREIJ ESTHER, SATIJN DAVID, VERPLOEGEN SANDRA, (...more)
2020, AU-2019231696-A1
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
GENMAB AS, Genmab (Denmark), RANGWALA RESHMA ABDULLA RANGWALA RESHMA ABDULLA, BREIJ ESTHER, SATIJN DAVID, (...more)
2019, WO-2019173523-A1
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
Genmab (Denmark), Genmab AS RANGWALA RESHMA ABDULLA, BREIJ ESTHER, SATIJN DAVID, (...more)
2019, CA-3091217-A1